Adaptive Biotechnologies CFO buys and sells shares on November 28.

Adaptive Biotechnologies Corporation (ADPT) has disclosed that Kyle Piskel, Chief Financial Officer, has recently made several transactions involving the company's shares. On November 28, 2025, Piskel acquired 11,980 shares at a price of $6.55 per share, 3,750 shares at $7.80 per share, and 94,384 shares at $12.14 per share. However, Piskel also sold 162,820 shares at $19.50 per share on the same date. These transactions reflect Piskel's confidence in the company's growth prospects and valuation.